Literature DB >> 15070919

Growth hormone and ghrelin responses to an oral glucose load in adolescent girls with anorexia nervosa and controls.

Madhusmita Misra1, Karen K Miller, David B Herzog, Kavitha Ramaswamy, Avichal Aggarwal, Cecilia Almazan, Gregory Neubauer, Jeffrey Breu, Anne Klibanski.   

Abstract

Anorexia nervosa (AN) is associated with high levels of GH and low levels of IGF-I suggestive of a nutritionally acquired lack of GH action or GH resistance. The suppression of GH levels after administration of inhibitors of GH secretion such as oral glucose is the definitive test to distinguish normal from pathological states of GH excess, such as acromegaly. However, suppression of GH by glucose has not been well characterized in states of adaptive GH excess, such as AN, especially in a younger adolescent population with relatively higher GH levels, compared with adults. In this study, we investigated GH suppression after a 100-g oral glucose load over a 1-h period in 19 adolescent girls with AN and 20 healthy controls of similar chronologic and bone age. We also compared nocturnal GH secretion characteristics by deconvolutional analysis in both groups to determine differences in secretory patterns between adolescents whose GH values suppressed vs. those whose values did not after oral glucose. Fasting levels of ghrelin, a GH secretagogue, and suppression of ghrelin with oral glucose were also determined to assess whether GH suppression or nonsuppression could be related to ghrelin values at respective time points. At 0 min (0') of the oral glucose tolerance test, girls with AN had significantly lower levels of glucose (P = 0.009) and higher levels of GH (P = 0.04) than controls. Nadir GH values were higher in AN than in controls (2.0 +/- 1.8 vs. 0.5 +/- 0.5 ng/ml, P = 0.001). Only 31.6% of girls with AN suppressed their GH values to 1 ng/ml or less vs. 85.0% of healthy adolescents (P = 0.0005). All healthy controls had nadir postglucose GH values of 2 ng/ml or less. Nadir GH concentrations during the oral glucose tolerance test correlated directly with all measures of GH secretion [basal (r = 0.37, P = 0.02), pulsatile (r = 0.56, P = 0.0002), and total (r = 0.57, P = 0.0002)]. Adolescent girls who did not suppress their GH values to 1 ng/ml or less had significantly higher levels of ghrelin at 0', 30', and 60' (P = 0.02, 0.004, and 0.008), significantly higher GH at 0' (P = 0.001), and higher nocturnal basal (P = 0.002), pulsatile (P = 0.05), and total GH secretion (P = 0.03) than those who did suppress below this level. Ghrelin values were higher in AN than in controls at each time point (P = 0.02, 0.0002, and 0.01 at 0', 30', and 60') but did not predict GH values at these time points. Adolescent girls with AN fail to adequately suppress their GH values after a 100-g oral glucose load. This lack of suppression may be related to the higher GH secretion seen in adolescents with this disorder. In contrast, all healthy adolescents suppress their GH values to 2 ng/ml or less but not 1 ng/ml or less after a glucose load. Although ghrelin values are higher in AN than in controls, we could not demonstrate a relationship between ghrelin and GH values. The inability of healthy girls to uniformly suppress GH levels to 1 ng/ml or less, a normal level defined for adults, may be related to higher GH secretion in the pubertal years, compared with adult life. Further studies are needed to define GH suppression in an adolescent population.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15070919     DOI: 10.1210/jc.2003-031861

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  30 in total

Review 1.  The neuroendocrine basis of anorexia nervosa and its impact on bone metabolism.

Authors:  Madhusmita Misra; Anne Klibanski
Journal:  Neuroendocrinology       Date:  2011-01-13       Impact factor: 4.914

Review 2.  Endocrine consequences of anorexia nervosa.

Authors:  Madhusmita Misra; Anne Klibanski
Journal:  Lancet Diabetes Endocrinol       Date:  2014-04-02       Impact factor: 32.069

Review 3.  Bone metabolism in anorexia nervosa.

Authors:  Pouneh K Fazeli; Anne Klibanski
Journal:  Curr Osteoporos Rep       Date:  2014-03       Impact factor: 5.096

4.  Abnormal relationships between the neural response to high- and low-calorie foods and endogenous acylated ghrelin in women with active and weight-recovered anorexia nervosa.

Authors:  Laura M Holsen; Elizabeth A Lawson; Kara Christensen; Anne Klibanski; Jill M Goldstein
Journal:  Psychiatry Res       Date:  2014-05-06       Impact factor: 3.222

5.  Nutrient intake in community-dwelling adolescent girls with anorexia nervosa and in healthy adolescents.

Authors:  Madhusmita Misra; Patrika Tsai; Ellen J Anderson; Jane L Hubbard; Katie Gallagher; Leslie A Soyka; Karen K Miller; David B Herzog; Anne Klibanski
Journal:  Am J Clin Nutr       Date:  2006-10       Impact factor: 7.045

Review 6.  Potential applications for rhIGF-I: Bone disease and IGFI.

Authors:  Marisol Bahamonde; Madhusmita Misra
Journal:  Growth Horm IGF Res       Date:  2020-03-23       Impact factor: 2.372

7.  Peptide YY levels across pubertal stages and associations with growth hormone.

Authors:  Benjamin Lloyd; Praful Ravi; Nara Mendes; Anne Klibanski; Madhusmita Misra
Journal:  J Clin Endocrinol Metab       Date:  2010-04-07       Impact factor: 5.958

Review 8.  Neuroendocrine consequences of anorexia nervosa in adolescents.

Authors:  Madhusmita Misra; Anne Klibanski
Journal:  Endocr Dev       Date:  2009-11-24

9.  Fibroblast growth factor-21 may mediate growth hormone resistance in anorexia nervosa.

Authors:  Pouneh K Fazeli; Madhusmita Misra; Mark Goldstein; Karen K Miller; Anne Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2009-11-19       Impact factor: 5.958

Review 10.  Systemic illness.

Authors:  Marta Bondanelli; Maria Chiara Zatelli; Maria Rosaria Ambrosio; Ettore C degli Uberti
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.